Clinical Liver Disease
© The American Association for the Study of Liver Diseases
Recently Published Issues
Current Issue:August 2015
Volume 6, Issue 2
Special Issue: Editorial, Palliative Care & Non-Vi...
Volume 6, Issue 1
Special Issue: The Future in Liver Medicine & Pall...
Volume 5, Issue 6
Special Issue: The Future in Liver Medicine, Liver...
Volume 5, Issue 5
Special Issue: Hepatic Encephalopathy & Liver Tran...
Volume 5, Issue 4
Special Issue: Liver and the Microbiome & Liver Tr...
NEW in Palliative Care:
Overview of Palliative Care and Hospice Services
Sara E. Wordingham, M.D. and Keith M. Swetz, M.D., M.A.
End-stage chronic liver disease (ESLD) affects thousands of Americans. Up to 10% of eligible patients will die without undergoing transplantation, and those who await transplantation may have high symptom burden, making palliative care consultation for those patients an important tool to improve quality of life.
Issues in the End-Stage Liver Disease Patient for Which Palliative Care Could Be Helpful
Paula Cox-North, Ph.D., A.R.N.P.
ESLD is often associated with multiple complications including ascites, hepatic encephalopathy, pain, and pruritus. Learn how to approach the meticulous management required.
Working With Palliative Care Services
Amanda J. Brisebois M.Sc., M.D., and Puneeta Tandon M.D.
While palliative care is often perceived as synonymous with the active process of dying, it is not only end of life care. All types of practitioners can provide palliative services, and palliative care principles and specialists can be helpful in a variety of clinical situations.
Overall Health-Related Quality of Life in Patients With End-Stage Liver Disease
Zobair Younossi, M.D., M.P.H., and Linda Henry Ph.D.
A ‘‘Good Death’’ With Irreversible Liver Disease: Talking With Patients and Families About Deteriorating Health and Dying
Kirsty Boyd, M.B.Ch.B.(Hon.), F.R.C.P. (Edin.), M.Med.Sci., Barbara Kimbell, Ph.D., Scott Murray, M.B.Ch.B., D.C.H., M.R.C.G.P., M.D., F.R.C.G.P., F.R.C.P.Ed., John Iredale D.M., F.R.C.P., F.Med.Sci., F.R.S.E.
Palliative Care for Patients with End-Stage Liver Disease: An Overview
Mina O. Rakoski, M.D., M.Sc. and Michael L. Volk, M.D., M.Sc., AGAF
Palliative Care for Patients With End-Stage Liver Disease: The Role of the Liver Team
Sean G. Kelly, M.D. and John P. Rice, M.D.
Is Palliative Care Appropriate in the Liver Transplant Candidate?
Rohit Pai M.D., Constantine J. Karvellas M.D., S.M.
Liver and the Microbiome
Guest Edited by Eamonn M.M. Quigley, MD, FRCP, FACP, FACG, FRCPI
Host-Microbiome Interactions in Health and Disease
Liam O’Mahony, PhD
Microbiome-Immune Interactions and Liver Disease
James H. Tabibian MD, PhD, Cyril Varghese MD, Steven P. O’Hara PhD, and Nicholas F. LaRusso MD
The Gut Microbiome: What Do We Know?
Francisco Guarner, MD, PhD
The Metabolic Role of the Microbiota
Wiley Barton B.Sc. Fergus Shanahan MD, Paul D. Cotter PhD, Orla O’Sullivan PhD
Is the Gut Microbiota Disturbed in Chronic Liver Disease?
Eamonn M.M. Quigley, MD, FRCP, FACP, FACG, FRCPI
Microbiome and Complications of Liver Disease
Jasmohan S. Bajaj, MD, MS, FACG, AGAF
Access CLD on the go.
Listen to the author interviews and readings of the full articles by subscribing to the iTunes podcast.
New Editorial Series: In My Opinion
Hepatitis C Treatment:
Popular in CLD's series on Hepatitis C:
Guest Edited by Donald M. Jensen, MD, FACP
New Therapies for Hepatitis C: Latin American Perspectives
Rafael Claudino Botero, MD, FACP, and Martin Tagle, MD
Learn about the unique challenges for treating Hepatitis C in Latin America, including a detailed country by country analysis.
Los Nuevos Tratamiento de Hepatitis C: Perspectivas Latinoamericanas
Non-viral Liver Infections
Guest Edited by Emily A. Blumberg, M.D.
Amebic Liver Abscess
Judith A. Anesi M.D., and Stephen Gluckman M.D.
Amebic liver abscesses are caused by Entamoeba histolytica, a protozoan parasite that is acquired via ingestion of food or water contaminated by human feces. While generally asymptomatic, it can cause amebic dysentery or even extraintestinal disease. Learn the epidemiology, clinical manifestations, diagnosis, and management.
Recognizing Clonorchiasis: A Foodborne Illness Leading to Significant Hepatobiliary Disease
Charitha Gowda, M.D., M.P.H.
Clonorchiasis, known as the Oriental liver fluke, is implicated in a wide spectrum of hepatobiliary disease ranging from asymptomatic infection to more severe liver disease including cholangitis or portal hypertension. Learn how to recognize the signs.
Oliver A. Cornely M.D., Christopher Bangard M.D., and Natalie I. Jaspers M.D.
Hepatosplenic candidiasis is a very rare disease, but is the most frequent form of chronic disseminated candidiasis. Learn how to recognize the signs and symptoms.
Pyogenic Liver Abscess
Sarah Longworth M.D. and Jennifer Han M.D., M.S.C.E.
Pyogenic liver abscess (PLA) is a rare disease. Although once uniformly fatal, advances in imaging modalities and antimicrobial therapy have led to significant improvements in outcomes.
The Future in Liver Medicine
Guest Edited by Meena Bansal, MD
Liver Fibrosis: Therapeutic Armory 40 Years On
John P. Iredale, FRCP, F Med Sci, FRSE, and Antonella Pellicoro, PhD
Histologic and Noninvasive Estimates of Liver Fibrosis
Pierre Bedossa, M.D., Ph.D., Keyur Patel, M.D., and Laurent Castera, M.D., Ph.D.
The Future of Hepatology: Embrace Change
Scott L. Friedman MD and Yael L. Friedman MA
Training the Next Generation of Hepatologist: What Will They Need to Know?
Dina L. Halegoua-De Marzio MD, and Steven K. Herrine MD
Personalized Management of Hepatocellular Carcinoma Based on Molecular Information: Future Prospects
Nicolas Goossens, MD, MSc Yujin Hoshida, MD, PhD
Increasing Impact of Drug-Induced Liver Injury
Paul H. Hayashi, MD, MPH and Naga P. Chalasani MD
Future Watch: Evolving Trends in the Management of Nonalcoholic Steatohepatitis
Arun J. Sanyal, MBBS, MD